Home / Compliance actions / 543225

FDA Warning Letter — BP

Case 543225 — FEI 3014107005

The FDA took a Warning Letter action against BP on Dec 21, 2017 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Dec 21, 2017
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Facility

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.